Circulation, 146, 657-672 Circulation : an official journal of the American Heart Association / ed.-in-chief Ephraim Donosco 146(9), 657-672 (2022). doi:10.1161/CIRCULATIONAHA.121.057807 Hagström, E, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Danchin, N, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Liberopoulos, E, Marx, N, McGinniss, J, Manvelian, G, Pordy, R, Scemama, M, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Investigators & Bøttcher, M 2022, ' Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab ', Circulation, vol. 146, no. 9, pp. 657-672 . https://doi.org/10.1161/CIRCULATIONAHA.121.057807 Circulation, vol 146, iss 9 Circulation, 146, 9, pp. 657-672 Circulation, Philadelphia : Lippincott Williams & Wilkins, 2022, vol. 146, iss. 9, p. 657-672 Circulation, 146(9), 657-672. LIPPINCOTT WILLIAMS & WILKINS
White, H D, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Erglis, A, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Lopes, R D, Mahaffey, K W, Moryusef, A, Pordy, R, Roe, M T, Sritara, P, Tricoci, P, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Davidsen, F & Videbaek, L 2019, ' Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial ', European Heart Journal, vol. 40, no. 33, pp. 2801-2809 . https://doi.org/10.1093/eurheartj/ehz299 European Heart Journal, 40(33), 2801-2809. OXFORD UNIV PRESS European Heart Journal Volume 40 Issue 33 European Heart Journal, 40(33), 2801-2809. Oxford University Press European heart journal EUROPEAN HEART JOURNAL r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname European heart journal 40(33), 2801-2809 (2019). doi:10.1093/eurheartj/ehz299 special issue: "Focus Issue on LIPIDS"